Format

Send to

Choose Destination
Sci Data. 2018 Feb 27;5:180015. doi: 10.1038/sdata.2018.15.

ImmPort, toward repurposing of open access immunological assay data for translational and clinical research.

Author information

1
Institute for Computational Health Sciences, University of California, San Francisco, CA 94158, USA.
2
Northrop Grumman Health Solutions, Rockville, MD 20850, USA.
3
Department of Philosophy, University at Buffalo, Buffalo, NY 14260, USA.
4
Enterprise Science and Computing Inc., Rockville, MD 20850, USA.
5
Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
6
Department of Immunology, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3200003, Israel.

Abstract

Immunology researchers are beginning to explore the possibilities of reproducibility, reuse and secondary analyses of immunology data. Open-access datasets are being applied in the validation of the methods used in the original studies, leveraging studies for meta-analysis, or generating new hypotheses. To promote these goals, the ImmPort data repository was created for the broader research community to explore the wide spectrum of clinical and basic research data and associated findings. The ImmPort ecosystem consists of four components-Private Data, Shared Data, Data Analysis, and Resources-for data archiving, dissemination, analyses, and reuse. To date, more than 300 studies have been made freely available through the Shared Data portal (www.immport.org/immport-open), which allows research data to be repurposed to accelerate the translation of new insights into discoveries.

PMID:
29485622
PMCID:
PMC5827693
DOI:
10.1038/sdata.2018.15
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center